Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Smoking cessation in patients with respiratory disease: existing treatments and future directions.

Rigotti NA.

Lancet Respir Med. 2013 May;1(3):241-50. doi: 10.1016/S2213-2600(13)70063-8. Epub 2013 May 3. Review.

PMID:
24429130
2.

Managing tobacco use: the neglected cardiovascular disease risk factor.

Rigotti NA, Clair C.

Eur Heart J. 2013 Nov;34(42):3259-67. doi: 10.1093/eurheartj/eht352. Epub 2013 Sep 7. Review.

3.

Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.

Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.

PMID:
22818870
5.

Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.

Lutz MA, Lovato P, Cuesta G.

Hosp Pract (1995). 2012 Feb;40(1):24-34. doi: 10.3810/hp.2012.02.945.

PMID:
22406880
6.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
7.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
8.

Smoking cessation and COPD.

Tønnesen P.

Eur Respir Rev. 2013 Mar 1;22(127):37-43. doi: 10.1183/09059180.00007212. Review.

9.
10.

Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.

Lutz MA, Lovato P, Cuesta G.

Hosp Pract (1995). 2012 Feb;40(1):35-43. doi: 10.3810/hp.2012.02.946.

PMID:
22406881
11.

Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.

Jiménez Ruiz CA, Ramos Pinedo A, Cicero Guerrero A, Mayayo Ulibarri M, Cristobal Fernández M, Lopez Gonzalez G.

Nicotine Tob Res. 2012 Sep;14(9):1035-9. doi: 10.1093/ntr/nts001. Epub 2012 Feb 17.

PMID:
22345320
12.

Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial.

Ferguson J, Docherty G, Bauld L, Lewis S, Lorgelly P, Boyd KA, McEwen A, Coleman T.

BMJ. 2012 Mar 23;344:e1696. doi: 10.1136/bmj.e1696.

13.

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.

Hoogendoorn M, Welsing P, Rutten-van Mölken MP.

Curr Med Res Opin. 2008 Jan;24(1):51-61.

PMID:
18021492
14.

Population-based smoking cessation strategies: a summary of a select group of evidence-based reviews.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(1):1-44. Epub 2010 Jan 1.

15.

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.

Walker N, Howe C, Bullen C, McRobbie H, Glover M, Parag V, Williman J, Veale R, Nosa V, Barnes J.

BMC Public Health. 2011 Nov 21;11:880. doi: 10.1186/1471-2458-11-880.

16.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
17.

Review: smoking cessation strategies in patients with lung disease.

Tsiapa G, Gkiozos I, Souliotis K, Syrigos K.

In Vivo. 2013 Mar-Apr;27(2):171-6. Review.

PMID:
23422475
18.

Smoking cessation intervention: an evidence-based approach.

Laniado-Laborín R.

Postgrad Med. 2010 Mar;122(2):74-82. doi: 10.3810/pgm.2010.03.2124. Review.

PMID:
20203458
19.

Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.

Getsios D, Marton JP, Revankar N, Ward AJ, Willke RJ, Rublee D, Ishak KJ, Xenakis JG.

Pharmacoeconomics. 2013 Sep;31(9):767-80. doi: 10.1007/s40273-013-0070-5.

PMID:
23821436
20.

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A.

Health Technol Assess. 2010 Oct;14(49):1-152, iii-iv. doi: 10.3310/hta14490. Review.

Items per page

Supplemental Content

Write to the Help Desk